The largest deal involved Clario taken by Thermo Fisher Scientific for $9B to enhance its clinical research business and to enable faster decision-making during drug development.
Seller Name
Clario
Buyer Name
Thermo Fisher Scientific
Deal Value
$9.0B
EV/S Multiple
7.5x
Link
Value Type
Featured Category